Selected research
Industry Research
Methotrexate Sodium Industry Research Report 2026
Market perspective
The global Methotrexate Sodium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Methotrexate Sodium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Methotrexate Sodium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Methotrexate Sodium include HOSPIRA, Qualitest(DAVA Pharmaceuticals), Roxane Laboratories Inc., STADA Pharmaceuticals, Inc, Teva USA(Barr Laboratories) and Mylan Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Methotrexate Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Methotrexate Sodium Market by Company
HOSPIRA
Qualitest(DAVA Pharmaceuticals)
Roxane Laboratories Inc.
STADA Pharmaceuticals, Inc
Teva USA(Barr Laboratories)
Mylan Pharmaceuticals Inc.
Methotrexate Sodium Segment by Type
Methotrexate Sodium Tablet
Methotrexate Sodium Solution
Methotrexate Sodium Segment by Application
Oral
Injection
Methotrexate Sodium Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Methotrexate Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Methotrexate Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Methotrexate Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate Sodium Tablet
- Methotrexate Sodium Solution
Applications
- Oral
- Injection
Companies covered
- HOSPIRA
- Qualitest(DAVA Pharmaceuticals)
- Roxane Laboratories Inc.
- STADA Pharmaceuticals, Inc
- Teva USA(Barr Laboratories)
- Mylan Pharmaceuticals Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Methotrexate Sodium Market Size (2021-2032)
- 2.2.2 Global Methotrexate Sodium Sales (2021-2032)
- 2.2.3 Global Methotrexate Sodium Market Average Price (2021-2032)
- 2.3 Methotrexate Sodium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Methotrexate Sodium Tablet
- 2.3.3 Methotrexate Sodium Solution
- 2.4 Methotrexate Sodium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oral
- 2.4.3 Injection
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Methotrexate Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Methotrexate Sodium Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Methotrexate Sodium Revenue of Manufacturers (2021-2026)
- 3.4 Global Methotrexate Sodium Average Price by Manufacturers (2021-2026)
- 3.5 Global Methotrexate Sodium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Methotrexate Sodium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Methotrexate Sodium, Product Type & Application
- 3.8 Global Manufacturers of Methotrexate Sodium, Established Date
- 3.9 Global Methotrexate Sodium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 HOSPIRA
- 4.1.1 HOSPIRA Company Information
- 4.1.2 HOSPIRA Business Overview
- 4.1.3 HOSPIRA Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 HOSPIRA Methotrexate Sodium Product Portfolio
- 4.1.5 HOSPIRA Recent Developments
- 4.2 Qualitest(DAVA Pharmaceuticals)
- 4.2.1 Qualitest(DAVA Pharmaceuticals) Company Information
- 4.2.2 Qualitest(DAVA Pharmaceuticals) Business Overview
- 4.2.3 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Product Portfolio
- 4.2.5 Qualitest(DAVA Pharmaceuticals) Recent Developments
- 4.3 Roxane Laboratories Inc.
- 4.3.1 Roxane Laboratories Inc. Company Information
- 4.3.2 Roxane Laboratories Inc. Business Overview
- 4.3.3 Roxane Laboratories Inc. Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roxane Laboratories Inc. Methotrexate Sodium Product Portfolio
- 4.3.5 Roxane Laboratories Inc. Recent Developments
- 4.4 STADA Pharmaceuticals, Inc
- 4.4.1 STADA Pharmaceuticals, Inc Company Information
- 4.4.2 STADA Pharmaceuticals, Inc Business Overview
- 4.4.3 STADA Pharmaceuticals, Inc Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 STADA Pharmaceuticals, Inc Methotrexate Sodium Product Portfolio
- 4.4.5 STADA Pharmaceuticals, Inc Recent Developments
- 4.5 Teva USA(Barr Laboratories)
- 4.5.1 Teva USA(Barr Laboratories) Company Information
- 4.5.2 Teva USA(Barr Laboratories) Business Overview
- 4.5.3 Teva USA(Barr Laboratories) Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Teva USA(Barr Laboratories) Methotrexate Sodium Product Portfolio
- 4.5.5 Teva USA(Barr Laboratories) Recent Developments
- 4.6 Mylan Pharmaceuticals Inc.
- 4.6.1 Mylan Pharmaceuticals Inc. Company Information
- 4.6.2 Mylan Pharmaceuticals Inc. Business Overview
- 4.6.3 Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Pharmaceuticals Inc. Methotrexate Sodium Product Portfolio
- 4.6.5 Mylan Pharmaceuticals Inc. Recent Developments
5 Global Methotrexate Sodium Market Scenario by Region
- 5.1 Global Methotrexate Sodium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Methotrexate Sodium Sales by Region: 2021-2032
- 5.2.1 Global Methotrexate Sodium Sales by Region: 2021-2026
- 5.2.2 Global Methotrexate Sodium Sales by Region: 2027-2032
- 5.3 Global Methotrexate Sodium Revenue by Region: 2021-2032
- 5.3.1 Global Methotrexate Sodium Revenue by Region: 2021-2026
- 5.3.2 Global Methotrexate Sodium Revenue by Region: 2027-2032
- 5.4 North America Methotrexate Sodium Market Facts & Figures by Country
- 5.4.1 North America Methotrexate Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Methotrexate Sodium Sales by Country (2021-2032)
- 5.4.3 North America Methotrexate Sodium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Methotrexate Sodium Market Facts & Figures by Country
- 5.5.1 Europe Methotrexate Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Methotrexate Sodium Sales by Country (2021-2032)
- 5.5.3 Europe Methotrexate Sodium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Methotrexate Sodium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Methotrexate Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Methotrexate Sodium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Methotrexate Sodium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Methotrexate Sodium Market Facts & Figures by Country
- 5.7.1 South America Methotrexate Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Methotrexate Sodium Sales by Country (2021-2032)
- 5.7.3 South America Methotrexate Sodium Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Methotrexate Sodium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Methotrexate Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Methotrexate Sodium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Methotrexate Sodium Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Methotrexate Sodium Sales by Type (2021-2032)
- 6.1.1 Global Methotrexate Sodium Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Methotrexate Sodium Sales Market Share by Type (2021-2032)
- 6.2 Global Methotrexate Sodium Revenue by Type (2021-2032)
- 6.2.1 Global Methotrexate Sodium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Methotrexate Sodium Revenue Market Share by Type (2021-2032)
- 6.3 Global Methotrexate Sodium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Methotrexate Sodium Sales by Application (2021-2032)
- 7.1.1 Global Methotrexate Sodium Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Methotrexate Sodium Sales Market Share by Application (2021-2032)
- 7.2 Global Methotrexate Sodium Revenue by Application (2021-2032)
- 7.2.1 Global Methotrexate Sodium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Methotrexate Sodium Revenue Market Share by Application (2021-2032)
- 7.3 Global Methotrexate Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Methotrexate Sodium Value Chain Analysis
- 8.1.1 Methotrexate Sodium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Methotrexate Sodium Production Mode & Process
- 8.2 Methotrexate Sodium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Methotrexate Sodium Distributors
- 8.2.3 Methotrexate Sodium Customers
9 Global Methotrexate Sodium Analyzing Market Dynamics
- 9.1 Methotrexate Sodium Industry Trends
- 9.2 Methotrexate Sodium Industry Drivers
- 9.3 Methotrexate Sodium Industry Opportunities and Challenges
- 9.4 Methotrexate Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst